A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States

Post –endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common adverse event after endoscopic retrograde cholangiopancreatography, and is responsible for substantial morbidity and health care expenditures of at least $200 million. Therapies for PEP prevention include pancrea tic stent placement (PSP), rectal indomethacin, sublingual nitrates, and aggressive lactated Ringer’s hydration. Our objective was to determine which PEP prophylactic strategies are cost effective.

Source: Clinical Gastroenterology and Hepatology - September 2, 2021 Category: Gastroenterology Authors: Nikhil R. Thiruvengadam, Monica Saumoy, Yecheskel Schneider, Sara Attala, Joseph Triggs, Peter Lee, Michael L. Kochman Source Type: research